Sergio Morandi
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Hemoglobinopathies and Related Disorders
Papers in
- Hematology 14
- Chronic Myeloid Leukemia Treatments 6
- Multiple Myeloma Research and Treatments 5
- Iron Metabolism and Disorders 2
- Acute Myeloid Leukemia Research 2
- Genetics 11
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- Giovanni Barosi (8 shared papers)Mario Cazzola (5 shared papers)Mario Stefanelli (4 shared papers)Giampaolo Merlini (3 shared papers)Carlomaurizio Montecucco (2 shared papers)Luigi Cavanna (1 shared paper)Carla Pieresca (1 shared paper)Daniele Bertoloni (1 shared paper)
- Journals
- Blood (4 papers)British Journal of Haematology (2 papers)The Hematology Journal (2 papers)Annals of Hematology (1 paper)Human Genetics (1 paper)
- Partner nations
- ItalyUnited KingdomUnited States
In The Last Decade
Sergio Morandi
28 papers receiving 431 citations
Peers
Comparison fields: 5 of 46
- Hematology 262
- Genetics 180
- Pathology and Forensic Medicine 108
- Oncology 86
- Public Health, Environmental and Occupational Health 91
Countries citing papers authored by Sergio Morandi
This map shows the geographic impact of Sergio Morandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergio Morandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergio Morandi more than expected).
Fields of papers citing papers by Sergio Morandi
This network shows the impact of papers produced by Sergio Morandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergio Morandi. The network helps show where Sergio Morandi may publish in the future.
Co-authors
The 25 scholars most cited alongside Sergio Morandi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 98 | |
| 2 | 2020 | 42 | |
| 3 | 1978 | 37 | |
| 4 | 2001 | 33 | |
| 5 | 2001 | 26 | |
| 6 | 2004 | 26 | |
| 7 | 2001 | 25 | |
| 8 | 1979 | 21 | |
| 9 | 2000 | 16 | |
| 10 | Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study. | 1999 | 15 |
| 11 | 1996 | 14 | |
| 12 | 1994 | 13 | |
| 13 | 2008 | 11 | |
| 14 | 1976 | 11 | |
| 15 | EVALUATING SURVIVAL AFTER ALLOGENEIC BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA IN CHRONIC PHASE - A COMPARISON OF TRANSPLANT VERSUS NO-TRANSPLANT IN A COHORT OF 258 PATIENTS 1ST SEEN IN ITALY BETWEEN 1984 AND 1986 | 1993 | 11 |
| 16 | An approach by means of mathematical models to the analysis of ferrokinetic data obtained by liquid scintillation counting of 59Fe. | 1976 | 11 |
| 17 | Mitoxantrone alone or in combination chemotherapy (VeMP) as second-line treatment in relapsed or refractory poor-prognosis non-Hodgkin's lymphoma. A report of the Non-Hodgkin's Lymphoma Co-operative Study Group (NHLCSG). | 1992 | 9 |
| 18 | 1988 | 8 | |
| 19 | 1978 | 7 | |
| 20 | 1987 | 6 |
About Sergio Morandi
Sergio Morandi is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Pathology and Forensic Medicine and Oncology, having authored 30 papers that have together received 459 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Chronic Myeloid Leukemia Treatments (6 papers), Multiple Myeloma Research and Treatments (5 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer Treatment and Pharmacology (3 papers), Iron Metabolism and Disorders (2 papers) and Acute Myeloid Leukemia Research (2 papers). The work is most often cited by research in Hematology (262 citations), Genetics (180 citations), Pathology and Forensic Medicine (108 citations), Oncology (86 citations) and Public Health, Environmental and Occupational Health (91 citations). Sergio Morandi has collaborated with scholars based in Italy, United Kingdom and United States. Frequent co-authors include Giovanni Barosi, Mario Cazzola, Mario Stefanelli, Giampaolo Merlini, Carlomaurizio Montecucco, Luigi Cavanna, Carla Pieresca, Daniele Bertoloni, Giovanni Grignani and Roberto Bettini. Their work appears in journals such as Blood, British Journal of Haematology, The Hematology Journal, Annals of Hematology and Human Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.